Nano Holdings, Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/02/11 | ¥-3.79 | ¥-10.97 | -189.5% |
| 2015/08/11 | ¥-6.90 | ¥-7.20 | -4.4% |
| 2015/05/13 | ¥-9.27 | ¥-6.03 | +35.0% |
| 2015/02/12 | ¥-10.80 | ¥4.67 | +143.2% |
Shareholder Composition
Updated 2026/08/01Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥202M | ¥136M | ¥109M | ¥174M |
| Gross Profit | ¥160M | ¥111M | ¥78M | ¥153M |
| Operating Income | -¥1,246M | -¥864M | -¥755M | -¥966M |
| Pretax Income | -¥1,246M | -¥864M | -¥833M | -¥918M |
| Net Income | -¥1,311M | -¥780M | -¥835M | -¥944M |
| EPS | -¥18.70 | -¥11.10 | -¥11.85 | -¥12.90 |
| Operating Margin | -616.26% | -637.91% | -696.07% | -553.58% |
| Balance Sheet | ||||
| Total Assets | ¥5,784M | ¥5,071M | ¥3,997M | ¥5,906M |
| Total Equity | ¥4,253M | ¥3,421M | ¥2,740M | ¥3,565M |
| Total Liabilities | ¥1,531M | ¥1,650M | ¥1,257M | ¥2,341M |
| Cash | ¥2,812M | ¥2,078M | ¥1,707M | ¥4,910M |
| Interest-bearing Debt | ¥1,109M | ¥1,109M | ¥540M | ¥1,600M |
| Equity Ratio | 73.53% | 67.47% | 68.55% | 60.36% |
| D/E Ratio | 0.26 | 0.32 | 0.20 | 0.45 |
| Cash Flow | ||||
| Operating CF | -¥1,087M | -¥585M | -¥402M | -¥817M |
| Investing CF | ¥1,208M | ¥793M | ¥588M | ¥2,262M |
| Financing CF | - | ¥4M | -¥569M | ¥2,222M |
| Free CF | -¥1,087M | -¥585M | -¥402M | -¥817M |
| Efficiency | ||||
| ROE | -30.82% | -22.80% | -30.49% | -26.47% |
| ROA | -22.66% | -15.38% | -20.90% | -15.98% |
Latest IR Information
-
Notification on Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions)
In the month, 260,000 shares of stock acquisition rights were issued, 2,600 rights were exercised (0.70%), and unexercised rights decreased from 268,250 to 265,650 shares. Overall exercise ratio 0.36%, details of the prior month’s figures disclosed. The indicated month lists...
Read more -
Notice of Implementation of Restricted Stock Compensation Plan | July 2026
Nano Holdings Inc. has issued new shares to directors, employees, and external collaborators as part of the implementation of a restricted stock compensation plan. The number of shares issued is approximately 5.62 million, with a total value of about ¥573...
Read more -
Notice Regarding Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Clause)
Read more -
Items related to business plan and growth potential
Read more -
Correction: Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Clause)
Correction carried out for the misstatement in the monthly exercise status for the 22nd stock acquisition right (with exercise price adjustment provision) for May 2026. The corrected portion is underlined, and the difference before and after correction is the number...
Read more
Latest News (5 items)
Company Information
About
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.
